Cargando…

Malignant Otitis Externa: Causes for Various Treatment Responses

OBJECTIVES: Malignant (necrotizing) otitis externa (MOE) is an aggressive form of skin inflammation of the external ear with a tendency to spread infection to the temporal bone. The study aimed to evaluate a causal relationship between treatment responses and clinical features in patients with MOE....

Descripción completa

Detalles Bibliográficos
Autores principales: Arsovic, Nenad, Radivojevic, Nemanja, Jesic, Snezana, Babac, Snezana, Cvorovic, Ljiljana, Dudvarski, Zoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The European Academy of Otology and Neurotology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224427/
https://www.ncbi.nlm.nih.gov/pubmed/32209516
http://dx.doi.org/10.5152/iao.2020.7709
_version_ 1783533896145567744
author Arsovic, Nenad
Radivojevic, Nemanja
Jesic, Snezana
Babac, Snezana
Cvorovic, Ljiljana
Dudvarski, Zoran
author_facet Arsovic, Nenad
Radivojevic, Nemanja
Jesic, Snezana
Babac, Snezana
Cvorovic, Ljiljana
Dudvarski, Zoran
author_sort Arsovic, Nenad
collection PubMed
description OBJECTIVES: Malignant (necrotizing) otitis externa (MOE) is an aggressive form of skin inflammation of the external ear with a tendency to spread infection to the temporal bone. The study aimed to evaluate a causal relationship between treatment responses and clinical features in patients with MOE. MATERIALS AND METHODS: In a retrospective, descriptive section study, the database was analyzed between January 2008 and December 2018 in our department, all patients with diagnosed MOE were identified. RESULTS: A total of 30 patients were evaluated, of which 27 men and 3 women. The youngest patient was 52 years old while he was eldest 88 years, (mean-71 years old). As the most common comorbidity, diabetes mellitus was found in 23 (76%) subjects. Median duration of symptoms was about 3 months. The most common isolated pathogen was Pseudomonas aeruginosa (47%). Patients with facial nerve palsy and erosion of temporal bone find on computerized tomography affect prolonged stationary treatment (Mean, SD 29.2±8.5 and 26,7±11.6 days), while 80% of patients with facial nerve palsy had recurrence of disease (p=0.005) with mean duration of clinical remission of 60±17.3 days. Overall length of treatment is also increased in the presence of comorbidities as well as in patients with cranial nerve involvement. CONCLUSION: Patients with cranial nerve involvement, erosion of temporal bone and presence of comorbidities affect prolonged treatment and adverse prognosis. Early diagnosis and initiation of aggressive therapy are essential for stopping the further spread of the disease and prevention of serious complications.
format Online
Article
Text
id pubmed-7224427
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The European Academy of Otology and Neurotology
record_format MEDLINE/PubMed
spelling pubmed-72244272020-05-15 Malignant Otitis Externa: Causes for Various Treatment Responses Arsovic, Nenad Radivojevic, Nemanja Jesic, Snezana Babac, Snezana Cvorovic, Ljiljana Dudvarski, Zoran J Int Adv Otol Original Article OBJECTIVES: Malignant (necrotizing) otitis externa (MOE) is an aggressive form of skin inflammation of the external ear with a tendency to spread infection to the temporal bone. The study aimed to evaluate a causal relationship between treatment responses and clinical features in patients with MOE. MATERIALS AND METHODS: In a retrospective, descriptive section study, the database was analyzed between January 2008 and December 2018 in our department, all patients with diagnosed MOE were identified. RESULTS: A total of 30 patients were evaluated, of which 27 men and 3 women. The youngest patient was 52 years old while he was eldest 88 years, (mean-71 years old). As the most common comorbidity, diabetes mellitus was found in 23 (76%) subjects. Median duration of symptoms was about 3 months. The most common isolated pathogen was Pseudomonas aeruginosa (47%). Patients with facial nerve palsy and erosion of temporal bone find on computerized tomography affect prolonged stationary treatment (Mean, SD 29.2±8.5 and 26,7±11.6 days), while 80% of patients with facial nerve palsy had recurrence of disease (p=0.005) with mean duration of clinical remission of 60±17.3 days. Overall length of treatment is also increased in the presence of comorbidities as well as in patients with cranial nerve involvement. CONCLUSION: Patients with cranial nerve involvement, erosion of temporal bone and presence of comorbidities affect prolonged treatment and adverse prognosis. Early diagnosis and initiation of aggressive therapy are essential for stopping the further spread of the disease and prevention of serious complications. The European Academy of Otology and Neurotology 2020-04 2020-03-23 /pmc/articles/PMC7224427/ /pubmed/32209516 http://dx.doi.org/10.5152/iao.2020.7709 Text en © Copyright 2020 The European Academy of Otology and Neurotology https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Original Article
Arsovic, Nenad
Radivojevic, Nemanja
Jesic, Snezana
Babac, Snezana
Cvorovic, Ljiljana
Dudvarski, Zoran
Malignant Otitis Externa: Causes for Various Treatment Responses
title Malignant Otitis Externa: Causes for Various Treatment Responses
title_full Malignant Otitis Externa: Causes for Various Treatment Responses
title_fullStr Malignant Otitis Externa: Causes for Various Treatment Responses
title_full_unstemmed Malignant Otitis Externa: Causes for Various Treatment Responses
title_short Malignant Otitis Externa: Causes for Various Treatment Responses
title_sort malignant otitis externa: causes for various treatment responses
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224427/
https://www.ncbi.nlm.nih.gov/pubmed/32209516
http://dx.doi.org/10.5152/iao.2020.7709
work_keys_str_mv AT arsovicnenad malignantotitisexternacausesforvarioustreatmentresponses
AT radivojevicnemanja malignantotitisexternacausesforvarioustreatmentresponses
AT jesicsnezana malignantotitisexternacausesforvarioustreatmentresponses
AT babacsnezana malignantotitisexternacausesforvarioustreatmentresponses
AT cvorovicljiljana malignantotitisexternacausesforvarioustreatmentresponses
AT dudvarskizoran malignantotitisexternacausesforvarioustreatmentresponses